Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308523108> ?p ?o ?g. }
- W4308523108 endingPage "103922" @default.
- W4308523108 startingPage "103922" @default.
- W4308523108 abstract "Treatment of aggressive triple-negative breast cancer (TNBC) is still challenging. Isoliquiritigenin (ISL) is a water-insoluble bioactive compound possessing high anti-TNBC capacity with less toxicity. The present study aimed to develop a safe and effective oral drug delivery system to improve the oral efficacy of ISL for TNBC therapeutics. ISL-loaded zein phosphatidylcholine hybrid nanoparticles (ISL@ZLH NPs) were constructed by a one-step solvent evaporation method. Optimization and characterization of ISL@ZLH NPs were performed. Cellular uptake in vitro and biodistribution of ZLH NPs in vivo were investigated. The pharmacokinetics of ISL@ZLH NPs in terms of ISL content in the plasma, organs, and tumor tissues were validated, and the anti-TNBC efficacy was evaluated. Encapsulation efficiency (96.75 ± 1.41%) and drug loading efficiency (6.56 ± 0.83%) were found in ISL@ZLH NPs. ISL@ZLH NPs were able to enhance the absorption of ISL in the tumor sites. Moreover, the upregulation of p27 and downregulation of EGFR and CDK4 were observed in ISL@ZLH NPs treated tumors. Collectively, oral intake of ISL@ZLH NPs would be translated into a potential clinical therapy strategy against TNBC." @default.
- W4308523108 created "2022-11-12" @default.
- W4308523108 creator A5020505798 @default.
- W4308523108 creator A5023168600 @default.
- W4308523108 creator A5030011737 @default.
- W4308523108 creator A5032823744 @default.
- W4308523108 creator A5034855502 @default.
- W4308523108 creator A5038805449 @default.
- W4308523108 creator A5043804454 @default.
- W4308523108 creator A5045070839 @default.
- W4308523108 creator A5050282309 @default.
- W4308523108 creator A5050979366 @default.
- W4308523108 creator A5052274720 @default.
- W4308523108 creator A5059412974 @default.
- W4308523108 creator A5064622071 @default.
- W4308523108 creator A5068978771 @default.
- W4308523108 creator A5071458554 @default.
- W4308523108 creator A5078753498 @default.
- W4308523108 creator A5080218853 @default.
- W4308523108 creator A5085318175 @default.
- W4308523108 date "2023-01-01" @default.
- W4308523108 modified "2023-10-16" @default.
- W4308523108 title "A tumor-targeted delivery of oral isoliquiritigenin through encapsulated zein phosphatidylcholine hybrid nanoparticles prevents triple-negative breast cancer" @default.
- W4308523108 cites W1964296201 @default.
- W4308523108 cites W1998781337 @default.
- W4308523108 cites W2003987803 @default.
- W4308523108 cites W2026271711 @default.
- W4308523108 cites W2069210379 @default.
- W4308523108 cites W2083228608 @default.
- W4308523108 cites W2085131775 @default.
- W4308523108 cites W2092524156 @default.
- W4308523108 cites W2138764777 @default.
- W4308523108 cites W2325775114 @default.
- W4308523108 cites W2518918243 @default.
- W4308523108 cites W2592497776 @default.
- W4308523108 cites W2610779774 @default.
- W4308523108 cites W2727357448 @default.
- W4308523108 cites W2755196285 @default.
- W4308523108 cites W2766441357 @default.
- W4308523108 cites W2767464756 @default.
- W4308523108 cites W2784360276 @default.
- W4308523108 cites W2885628094 @default.
- W4308523108 cites W2893551450 @default.
- W4308523108 cites W2911718257 @default.
- W4308523108 cites W2921451512 @default.
- W4308523108 cites W2924592995 @default.
- W4308523108 cites W2935683372 @default.
- W4308523108 cites W2941157893 @default.
- W4308523108 cites W3015729812 @default.
- W4308523108 cites W3021977647 @default.
- W4308523108 cites W3029895923 @default.
- W4308523108 cites W3030122455 @default.
- W4308523108 cites W3036172594 @default.
- W4308523108 cites W3115720442 @default.
- W4308523108 cites W3173701463 @default.
- W4308523108 cites W3186007287 @default.
- W4308523108 cites W3202560731 @default.
- W4308523108 cites W3210412454 @default.
- W4308523108 cites W3217146693 @default.
- W4308523108 cites W4200536364 @default.
- W4308523108 cites W4205935124 @default.
- W4308523108 cites W4223969474 @default.
- W4308523108 cites W4225824227 @default.
- W4308523108 cites W4283786410 @default.
- W4308523108 cites W4295067436 @default.
- W4308523108 doi "https://doi.org/10.1016/j.jddst.2022.103922" @default.
- W4308523108 hasPublicationYear "2023" @default.
- W4308523108 type Work @default.
- W4308523108 citedByCount "4" @default.
- W4308523108 countsByYear W43085231082023 @default.
- W4308523108 crossrefType "journal-article" @default.
- W4308523108 hasAuthorship W4308523108A5020505798 @default.
- W4308523108 hasAuthorship W4308523108A5023168600 @default.
- W4308523108 hasAuthorship W4308523108A5030011737 @default.
- W4308523108 hasAuthorship W4308523108A5032823744 @default.
- W4308523108 hasAuthorship W4308523108A5034855502 @default.
- W4308523108 hasAuthorship W4308523108A5038805449 @default.
- W4308523108 hasAuthorship W4308523108A5043804454 @default.
- W4308523108 hasAuthorship W4308523108A5045070839 @default.
- W4308523108 hasAuthorship W4308523108A5050282309 @default.
- W4308523108 hasAuthorship W4308523108A5050979366 @default.
- W4308523108 hasAuthorship W4308523108A5052274720 @default.
- W4308523108 hasAuthorship W4308523108A5059412974 @default.
- W4308523108 hasAuthorship W4308523108A5064622071 @default.
- W4308523108 hasAuthorship W4308523108A5068978771 @default.
- W4308523108 hasAuthorship W4308523108A5071458554 @default.
- W4308523108 hasAuthorship W4308523108A5078753498 @default.
- W4308523108 hasAuthorship W4308523108A5080218853 @default.
- W4308523108 hasAuthorship W4308523108A5085318175 @default.
- W4308523108 hasConcept C112705442 @default.
- W4308523108 hasConcept C121608353 @default.
- W4308523108 hasConcept C126322002 @default.
- W4308523108 hasConcept C150903083 @default.
- W4308523108 hasConcept C171250308 @default.
- W4308523108 hasConcept C185592680 @default.
- W4308523108 hasConcept C192562407 @default.
- W4308523108 hasConcept C202751555 @default.
- W4308523108 hasConcept C207001950 @default.